Borrego P - Search Results

1

Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain.

Palladino C, Ezeonwumelu IJ, Mate-Cano I, Borrego P, Martínez-Román P, Arca-Lafuente S, Resino S, Taveira N, Briz V. Palladino C, et al. Among authors: borrego p. Sci Rep. 2020 Aug 3;10(1):13024. doi: 10.1038/s41598-020-69692-7. Sci Rep. 2020. PMID: 32747734 Free PMC article.

2

The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.

Borrego P, Marcelino JM, Rocha C, Doroana M, Antunes F, Maltez F, Gomes P, Novo C, Barroso H, Taveira N. Borrego P, et al. Retrovirology. 2008 Sep 8;5:78. doi: 10.1186/1742-4690-5-78. Retrovirology. 2008. PMID: 18778482 Free PMC article.

3

Envelope-specific antibody response in HIV-2 infection: C2V3C3-specific IgG response is associated with disease progression.

Marcelino JM, Nilsson C, Barroso H, Gomes P, Borrego P, Maltez F, Rosado L, Doroana M, Antunes F, Taveira N. Marcelino JM, et al. Among authors: borrego p. AIDS. 2008 Nov 12;22(17):2257-65. doi: 10.1097/QAD.0b013e3283155546. AIDS. 2008. PMID: 18981765

4

Genetic diversity and drug resistance profiles in HIV type 1- and HIV type 2-infected patients from Cape Verde Islands.

Oliveira V, Bártolo I, Borrego P, Rocha C, Valadas E, Barreto J, Almeida E, Antunes F, Taveira N. Oliveira V, et al. Among authors: borrego p. AIDS Res Hum Retroviruses. 2012 May;28(5):510-22. doi: 10.1089/AID.2011.0174. Epub 2011 Sep 19. AIDS Res Hum Retroviruses. 2012. PMID: 21902592

5

Origin and epidemiological history of HIV-1 CRF14_BG.

Bártolo I, Abecasis AB, Borrego P, Barroso H, McCutchan F, Gomes P, Camacho R, Taveira N. Bártolo I, et al. Among authors: borrego p. PLoS One. 2011;6(9):e24130. doi: 10.1371/journal.pone.0024130. Epub 2011 Sep 28. PLoS One. 2011. PMID: 21969855 Free PMC article.

6

Baseline susceptibility of primary HIV-2 to entry inhibitors.

Borrego P, Calado R, Marcelino JM, Bártolo I, Rocha C, Cavaco-Silva P, Doroana M, Antunes F, Maltez F, Caixas U, Barroso H, Taveira N. Borrego P, et al. Antivir Ther. 2012;17(3):565-70. doi: 10.3851/IMP1996. Epub 2012 Jan 25. Antivir Ther. 2012. PMID: 22293827 Free article.

7

Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.

Marcelino JM, Borrego P, Nilsson C, Família C, Barroso H, Maltez F, Doroana M, Antunes F, Quintas A, Taveira N. Marcelino JM, et al. Among authors: borrego p. AIDS. 2012 Nov 28;26(18):2275-84. doi: 10.1097/QAD.0b013e328359a89d. AIDS. 2012. PMID: 23151495

8

An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity.

Borrego P, Calado R, Marcelino JM, Pereira P, Quintas A, Barroso H, Taveira N. Borrego P, et al. AIDS. 2013 Apr 24;27(7):1081-90. doi: 10.1097/QAD.0b013e32835edc1d. AIDS. 2013. PMID: 23324659

9

HIV-2 susceptibility to entry inhibitors.

Borrego P, Taveira N. Borrego P, et al. AIDS Rev. 2013 Jan-Mar;15(1):49-61. AIDS Rev. 2013. PMID: 23449229 Review.

10

Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response.

Rocha C, Calado R, Borrego P, Marcelino JM, Bártolo I, Rosado L, Cavaco-Silva P, Gomes P, Família C, Quintas A, Skar H, Leitner T, Barroso H, Taveira N. Rocha C, et al. Among authors: borrego p. Retrovirology. 2013 Oct 24;10:110. doi: 10.1186/1742-4690-10-110. Retrovirology. 2013. PMID: 24156513 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page